Consumer · Drugstore Chains
CVS Health Corporation
$89.37 -0.15 (-0.17%) Pre-market $90.48 (+1.07%) ≈ ₹8,388 a share
Key numbers
- Market value
- $114.35B
- P/E (TTM)
- 10.4
- Forward P/E
- 11.0
- EPS (TTM)
- $8.59
- Dividend yield
- 2.98%
- Beta
- 0.58
- Day range
- $88.61 – $90.33
- 52-week range
- $69.51 – $110.68
- Volume
- 1,435,153
- 10-day avg volume
- $15.55M
- Revenue (TTM)
- $420.61B
- EBITDA (TTM)
- $19.83B
- Gross margin
- 14.2%
- Net margin
- 2.6%
- Return on equity
- 14.4%
- Debt / equity
- 75.4%
- Price / sales
- 0.27
- Shares out
- 1.28B
Quarterly results
Results for each quarter
Last 12 quarters from 10-Q and 10-K filings with the US SEC. Q4 = full year minus the first three quarters. Hover a bar to see the number.
Revenue and net income
Revenue · QoQ (vs last quarter)
Revenue · YoY (vs a year ago)
Net income · QoQ (vs last quarter)
Net income · YoY (vs a year ago)
| US$ | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $93.81B | $88.44B | $91.23B | $95.43B | $97.71B | $94.59B | $98.92B | $102.87B | $105.69B | $100.43B | $106.10B | $108.40B |
| Cost of revenue | $57.42B | $48.07B | $50.00B | $52.95B | $55.27B | $51.06B | $54.01B | $57.05B | $59.06B | $55.44B | $58.86B | $61.19B |
| Gross profit | $36.39B | $40.36B | $41.24B | $42.48B | $42.44B | $43.53B | $44.91B | $45.83B | $46.63B | $44.98B | $47.23B | $47.21B |
| Gross margin | 38.8% | 45.6% | 45.2% | 44.5% | 43.4% | 46.0% | 45.4% | 44.5% | 44.1% | 44.8% | 44.5% | 43.6% |
| Operating income | $3.37B | $2.27B | $3.05B | $832.00M | $2.37B | $3.37B | $2.38B | $-3.21B | $2.11B | $4.68B | $4.70B | $3.57B |
| Operating margin | 3.6% | 2.6% | 3.3% | 0.9% | 2.4% | 3.6% | 2.4% | -3.1% | 2.0% | 4.7% | 4.4% | 3.3% |
| Interest expense | $690.00M | $716.00M | $732.00M | $752.00M | $758.00M | $785.00M | $763.00M | $784.00M | $787.00M | $774.00M | $757.00M | $747.00M |
| Pre-tax income | $2.71B | $1.58B | $2.34B | $105.00M | $2.13B | $2.62B | $1.65B | $-3.48B | $1.35B | $3.94B | $3.98B | $2.85B |
| Income tax | $658.00M | $456.00M | $569.00M | $34.00M | $503.00M | $835.00M | $634.00M | $508.00M | $-1.57B | $981.00M | $982.00M | $678.00M |
| Net income | $2.05B | $1.11B | $1.77B | $87.00M | $1.64B | $1.78B | $1.02B | $-3.98B | $2.94B | $2.94B | $2.98B | $2.17B |
| Net margin | 2.2% | 1.3% | 1.9% | 0.1% | 1.7% | 1.9% | 1.0% | -3.9% | 2.8% | 2.9% | 2.8% | 2.0% |
| EPS (diluted) | — | $0.88 | $1.41 | $0.07 | — | $1.41 | $0.80 | $-3.13 | — | $2.30 | $2.31 | $1.68 |
Income statement
Results for each year
8 fiscal years from the company's 10-K filings with the US SEC.
Revenue, gross profit and net income
Revenue · YoY (vs a year ago)
Net income · YoY (vs a year ago)
EPS (diluted) · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $194.58B | $256.78B | $268.71B | $292.11B | $322.47B | $357.78B | $372.81B | $402.07B |
| Revenue growth | — | 32.0% | 4.6% | 8.7% | 10.4% | 10.9% | 4.2% | 7.8% |
| Cost of revenue | $156.45B | $158.72B | $163.98B | $175.80B | $196.89B | $217.10B | $206.29B | $221.17B |
| Gross profit | $38.13B | $98.06B | $104.73B | $116.31B | $125.58B | $140.68B | $166.52B | $180.90B |
| Gross margin | 19.6% | 38.2% | 39.0% | 39.8% | 38.9% | 39.3% | 44.7% | 45.0% |
| Operating income | $4.02B | $11.99B | $13.91B | $13.31B | $7.95B | $13.74B | $8.52B | $4.66B |
| Operating margin | 2.1% | 4.7% | 5.2% | 4.6% | 2.5% | 3.8% | 2.3% | 1.2% |
| Depreciation & amortisation | $2.72B | $4.37B | $4.44B | $4.49B | $4.22B | $4.37B | $4.60B | $4.61B |
| Interest expense | $2.62B | $3.04B | $2.91B | $2.50B | $2.29B | $2.66B | $2.96B | $3.12B |
| Pre-tax income | $1.41B | $9.00B | $9.77B | $10.54B | $5.84B | $11.17B | $6.15B | $2.14B |
| Income tax | $2.00B | $2.37B | $2.57B | $2.55B | $1.51B | $2.81B | $1.56B | $408.00M |
| Tax rate | 142.4% | 26.3% | 26.3% | 24.2% | 25.9% | 25.1% | 25.4% | 19.1% |
| Net income | $-594.00M | $6.63B | $7.18B | $8.00B | $4.31B | $8.34B | $4.61B | $1.77B |
| Net margin | -0.3% | 2.6% | 2.7% | 2.7% | 1.3% | 2.3% | 1.2% | 0.4% |
| EPS (diluted) | $-0.57 | $5.08 | $5.46 | $6.02 | $3.26 | $6.47 | $3.66 | $1.39 |
Balance sheet
Assets and debt
At each fiscal year end.
Equity, debt and cash
Shareholders' equity · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4.06B | $5.68B | $7.85B | $9.41B | $12.95B | $8.20B | $8.59B | $8.45B |
| Short-term investments | $2.52B | $2.37B | $3.00B | $3.12B | $2.78B | $3.26B | $2.41B | $2.15B |
| Current assets | $45.24B | $50.30B | $56.37B | $60.01B | $65.63B | $67.86B | $68.65B | $74.71B |
| Total assets | $196.46B | $222.45B | $230.72B | $233.00B | $228.28B | $249.73B | $253.22B | $253.54B |
| Current liabilities | $44.01B | $53.30B | $62.02B | $67.81B | $69.42B | $79.19B | $84.61B | $88.69B |
| Long-term debt | $71.44B | $64.70B | — | — | — | — | — | — |
| Short-term debt | $1.27B | $3.78B | — | — | — | — | — | — |
| Total debt | $72.71B | $68.48B | — | — | — | — | — | — |
| Total liabilities | $137.91B | $158.28B | $161.01B | $157.62B | $156.51B | $173.09B | $177.49B | $178.16B |
| Shareholders' equity | $58.23B | $63.86B | $69.39B | $75.08B | $71.47B | $76.46B | $75.56B | $75.21B |
| Current ratio | 1.03 | 0.94 | 0.91 | 0.88 | 0.95 | 0.86 | 0.81 | 0.84 |
| Debt / equity | 1.25 | 1.07 | — | — | — | — | — | — |
| Return on equity | -1.0% | 10.4% | 10.3% | 10.7% | 6.0% | 10.9% | 6.1% | 2.4% |
Cash flow
Cash coming in and going out
Free cash flow = cash from operations minus capital spending. Shareholder returns = dividends + buybacks.
Free cash flow and shareholder returns
Operating cash flow · YoY (vs a year ago)
Free cash flow · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | $8.87B | $12.85B | $15.87B | $18.27B | $16.18B | $13.43B | $9.11B | $10.64B |
| Capital spending | $-2.04B | $-2.46B | $-2.44B | $-2.52B | $-2.73B | $-3.03B | $-2.78B | $-2.83B |
| Free cash flow | $6.83B | $10.39B | $13.43B | $15.75B | $13.45B | $10.40B | $6.33B | $7.81B |
| FCF margin | 3.5% | 4.0% | 5.0% | 5.4% | 4.2% | 2.9% | 1.7% | 1.9% |
| Stock-based pay | $280.00M | $453.00M | $400.00M | $484.00M | $447.00M | $588.00M | $540.00M | $535.00M |
| Cash from investing | $-43.29B | $-3.34B | $-5.53B | $-5.26B | $-5.05B | $-20.89B | $-7.61B | $-5.87B |
| Cash from financing | $36.82B | $-7.65B | $-7.70B | $-11.36B | $-10.52B | $2.68B | $-1.14B | $-4.94B |
| Dividends paid | $-2.04B | $-2.60B | $-2.62B | $-2.63B | $-2.91B | $-3.13B | $-3.37B | $-3.40B |
| Share buybacks | $0 | $0 | $0 | $0 | $-3.50B | $-2.01B | $-3.02B | $0 |
About
About CVS Health Corporation
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores.
From Wikipedia (CC BY-SA 4.0).
Company details
- Company name
- CVS Health Corporation
- Ticker
- CVS
- Exchange
- NYSE
- ISIN
- US1266501006
- SEC CIK
- 0000064803
- Sector
- Consumer
- Industry
- Drugstore Chains
- SEC industry (SIC)
- Retail-drug Stores And Proprietary Stores (5912)
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Filer type
- Large accelerated filer
- Latest annual report (10-K)
- 10 Feb 2026
- CEO
- J. David Joyner
- Chair
- J. David Joyner
- Headquarters
- Rhode Island
- Address
- One Cvs Dr., Woonsocket, Ri 02895
- Founded
- 1963
- Employees
- 300,000
- Formerly known as
- Cvs Caremark Corp, Cvs/caremark Corp
- Trades in
- US dollars (USD)
- Website
- cvshealth.com
News
Latest news
From Google News; each link opens the publisher's story.
Peers
Others in Consumer
Quotes from CNBC (may be delayed), financials from SEC EDGAR, profile from global-stock-logos (MIT). Information only, not investment advice.